Company Quick10K Filing
Quick10K
Colgate Palmolive
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$70.85 859 $60,830
10-Q 2019-03-31 Quarter: 2019-03-31
10-K 2018-12-31 Annual: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-Q 2018-06-30 Quarter: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-K 2017-12-31 Annual: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-Q 2017-06-30 Quarter: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-K 2016-12-31 Annual: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-Q 2016-06-30 Quarter: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-K 2015-12-31 Annual: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-Q 2015-06-30 Quarter: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-K 2014-12-31 Annual: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-Q 2014-06-30 Quarter: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-K 2013-12-31 Annual: 2013-12-31
8-K 2019-07-11 Other Events, Exhibits
8-K 2019-06-18 Officers
8-K 2019-05-10 Officers, Shareholder Vote
8-K 2019-04-26 Earnings, Exhibits
8-K 2019-03-14 Officers, Exhibits
8-K 2019-02-21 Officers, Exhibits
8-K 2019-02-11 Officers, Exhibits
8-K 2019-01-25 Earnings, Exhibits
8-K 2019-01-25 Earnings, Exhibits
8-K 2018-10-26 Earnings, Exhibits
8-K 2018-10-10 Exhibits
8-K 2018-09-13 Officers, Exhibits
8-K 2018-07-27 Earnings, Exhibits
8-K 2018-07-11 Officers
8-K 2018-06-18 Officers, Other Events, Exhibits
8-K 2018-05-11 Shareholder Vote
8-K 2018-05-04 Officers
8-K 2018-03-19 Other Events, Exhibits
8-K 2018-03-07 Other Events, Exhibits
8-K 2018-01-26 Earnings, Exhibits
STZ Constellation Brands 38,630
CXP Columbia Property Trust 2,570
PSEC Prospect Capital 2,470
CTS CTS 939
ANIK Anika Therapeutics 564
WHF Whitehorse Finance 291
AAMC Altisource Asset Management 38
TRT Trio-Tech 11
NVAX Novavax 8
OMVS On The Move Systems 0
CL 2019-03-31
Part I. Financial Information
Part II. Other Information
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
EX-31.A exhibit31a_33119xq119.htm
EX-31.B exhibit31b_33119xq119.htm
EX-32 exhibit32_33119xq119.htm

Colgate Palmolive Earnings 2019-03-31

CL 10Q Quarterly Report

Balance SheetIncome StatementCash Flow

10-Q 1 cl-3312019x10q.htm 10-Q Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________________
 FORM 10-Q
_________________________
 (Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2019
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from________ to________ .
Commission File Number: 1-644
COLGATE-PALMOLIVE COMPANY
(Exact name of registrant as specified in its charter)
DELAWARE
13-1815595
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
 
300 Park Avenue, New York, New York
10022
(Address of principal executive offices)
(Zip Code)
(212) 310-2000
(Registrant’s telephone number, including area code)
NO CHANGES
(Former name, former address and former fiscal year, if changed since last report)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes    No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    
Yes   No  
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 
Yes No 
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date:
Class
 
Shares Outstanding
 
Date
Common stock, $1.00 par value
 
858,514,915
 
March 31, 2019





PART I.    FINANCIAL INFORMATION


COLGATE-PALMOLIVE COMPANY
 Condensed Consolidated Statements of Income
 (Dollars in Millions Except Per Share Amounts)
(Unaudited)
 
 
Three Months Ended
 
March 31,
 
2019
 
2018
Net sales
$
3,884

 
$
4,002

Cost of sales
1,597

 
1,594

Gross profit
2,287

 
2,408

Selling, general and administrative expenses
1,365

 
1,392

Other (income) expense, net
43

 
33

Operating profit
879

 
983

Non-service related postretirement costs
25

 
24

Interest (income) expense, net
40

 
35

Income before income taxes
814

 
924

Provision for income taxes
214

 
246

Net income including noncontrolling interests
600

 
678

Less: Net income attributable to noncontrolling interests
40

 
44

Net income attributable to Colgate-Palmolive Company
$
560

 
$
634

 
 
 
 
Earnings per common share, basic
$
0.65

 
$
0.72

 
 
 
 
Earnings per common share, diluted
$
0.65

 
$
0.72






See Notes to Condensed Consolidated Financial Statements.

2





COLGATE-PALMOLIVE COMPANY
 Condensed Consolidated Statements of Comprehensive Income
 (Dollars in Millions)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2019
 
2018
Net income including noncontrolling interests
$
600

 
$
678

Other comprehensive income (loss), net of tax:
 
 
 
Cumulative translation adjustments
26

 
108

Retirement plans and other retiree benefit adjustments
12

 
14

     Gains (losses) on cash flow hedges
(5
)
 
(1
)
Total Other comprehensive income (loss), net of tax
33

 
121

Total Comprehensive income including noncontrolling interests
633

 
799

Less: Net income attributable to noncontrolling interests
40

 
44

Less: Cumulative translation adjustments attributable to noncontrolling interests
5

 
3

Total Comprehensive income attributable to noncontrolling interests
45

 
47

Total Comprehensive income attributable to Colgate-Palmolive Company
$
588

 
$
752



See Notes to Condensed Consolidated Financial Statements.

3



COLGATE-PALMOLIVE COMPANY
 Condensed Consolidated Balance Sheets
 (Dollars in Millions)
(Unaudited)
 
March 31,
2019
 
December 31,
2018
Assets
 
 
 
Current Assets
 
 
 
Cash and cash equivalents
$
843

 
$
726

Receivables (net of allowances of $84 and $82, respectively)
1,547

 
1,400

Inventories
1,278

 
1,250

Other current assets
465

 
417

Total current assets
4,133

 
3,793

Property, plant and equipment:
 

 
 

Cost
8,398

 
8,336

Less: Accumulated depreciation
(4,577
)
 
(4,455
)
 
3,821

 
3,881

Goodwill
2,517

 
2,530

Other intangible assets, net
1,612

 
1,637

Deferred income taxes
164

 
152

Other assets
636

 
168

Total assets
$
12,883

 
$
12,161

Liabilities and Shareholders’ Equity
 

 
 

Current Liabilities
 

 
 

Notes and loans payable
$
5

 
$
12

Current portion of long-term debt
1

 

Accounts payable
1,215

 
1,222

Accrued income taxes
400

 
411

Other accruals
2,244

 
1,696

Total current liabilities
3,865

 
3,341

Long-term debt
6,655

 
6,354

Deferred income taxes
306

 
235

Other liabilities
2,267

 
2,034

Total liabilities
13,093

 
11,964

Shareholders’ Equity
 

 
 

Common stock
1,466

 
1,466

Additional paid-in capital
2,241

 
2,204

Retained earnings
21,436

 
21,615

Accumulated other comprehensive income (loss)
(4,160
)
 
(4,188
)
Unearned compensation
(3
)
 
(3
)
Treasury stock, at cost
(21,532
)
 
(21,196
)
Total Colgate-Palmolive Company shareholders’ equity
(552
)
 
(102
)
Noncontrolling interests
342

 
299

Total equity
(210
)
 
197

Total liabilities and equity
$
12,883

 
$
12,161



See Notes to Condensed Consolidated Financial Statements.

4




COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Cash Flows
(Dollars in Millions)
(Unaudited)
 
Three Months Ended
 
March 31,
 
2019
 
2018
Operating Activities
 
 
 
Net income including noncontrolling interests
$
600

 
$
678

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
 

 
 

Depreciation and amortization
128

 
129

Restructuring and termination benefits, net of cash
5

 
(25
)
Stock-based compensation expense
17

 
28

Deferred income taxes
53

 
13

Voluntary benefit plan contributions
(102
)
 

Cash effects of changes in:
 
 
 
Receivables
(145
)
 
(211
)
Inventories
(32
)
 
(33
)
Accounts payable and other accruals
44

 
33

Other non-current assets and liabilities
37

 
4

Net cash provided by operations
605


616

Investing Activities
 

 
 

Capital expenditures
(71
)
 
(118
)
Purchases of marketable securities and investments
(27
)
 
(38
)
Payment for acquisitions, net of cash acquired

 
(727
)
Other

 
2

Net cash used in investing activities
(98
)
 
(881
)
Financing Activities
 

 
 

Principal payments on debt
(1,774
)
 
(2,079
)
Proceeds from issuance of debt
2,076

 
2,226

Dividends paid
(366
)
 
(352
)
Purchases of treasury shares
(399
)
 
(351
)
Proceeds from exercise of stock options
71

 
119

Net cash used in financing activities
(392
)
 
(437
)
Effect of exchange rate changes on Cash and cash equivalents
2

 
18

Net increase (decrease) in Cash and cash equivalents
117

 
(684
)
Cash and cash equivalents at beginning of the period
726

 
1,535

Cash and cash equivalents at end of the period
$
843

 
$
851

Supplemental Cash Flow Information
 

 
 

Income taxes paid
$
149

 
$
163


See Notes to Condensed Consolidated Financial Statements.

5




COLGATE-PALMOLIVE COMPANY
Condensed Consolidated Statements of Changes in Shareholders Equity
(Dollars in Millions)
(Unaudited)
Three Months Ended March 31, 2019
 
Colgate-Palmolive Company Shareholders’ Equity
 
Noncontrolling
Interests
 
Common
Stock
 
Additional
Paid-in
Capital
 
Unearned
Compensation
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)(1)
 
 
Balance, December 31, 2018
$
1,466

 
$
2,204

 
$
(3
)
 
$
(21,196
)
 
$
21,615

 
$
(4,188
)
 
$
299

Net income
 

 
 

 
 

 
 

 
560

 
 
 
40

Other comprehensive income (loss), net of tax
 

 
 

 
 

 
 

 
 
 
28

 
5

Dividends ($0.85/per share)*
 

 
 

 
 

 
 

 
(734
)
 
 

 
(2
)
Stock-based compensation expense
 

 
17

 
 

 
 

 
 

 
 

 
 

Shares issued for stock options
 

 
33

 
 

 
49

 
 

 
 

 
 

Shares issued for restricted stock units
 
 
(13
)
 
 
 
13

 
 
 
 
 
 
Treasury stock acquired
 

 
 

 
 

 
(399
)
 
 

 
 

 
 

Other
 

 


 


 
1

 
(5
)
 


 


Balance, March 31, 2019
$
1,466

 
$
2,241

 
$
(3
)
 
$
(21,532
)
 
$
21,436

 
$
(4,160
)
 
$
342


Three Months Ended March 31, 2018
 
Colgate-Palmolive Company Shareholders’ Equity
 
Noncontrolling
Interests
 
Common
Stock
 
Additional
Paid-in
Capital
 
Unearned
Compensation
 
Treasury
Stock
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Income (Loss)(1)
 
 
Balance, December 31, 2017
$
1,466

 
$
1,984

 
$
(5
)
 
$
(20,181
)
 
$
20,531

 
$
(3,855
)
 
$
303

Net income
 

 
 

 
 

 
 

 
634

 
 
 
44

Other comprehensive income (loss), net of tax
 

 
 

 
 

 
 

 
 
 
118

 
3

Dividends ($0.82/per share)*
 

 
 

 
 

 
 

 
(718
)
 
 

 
 
Stock-based compensation expense
 

 
28

 
 

 
 

 
 

 
 

 
 

Shares issued for stock options
 

 
48

 
 

 
77

 
 

 
 

 
 

Shares issued for restricted stock units
 
 
(12
)
 
 
 
12

 
 
 
 
 
 
Treasury stock acquired
 

 
 

 
 

 
(351
)
 
 

 
 

 
 

Other
 

 
(1
)
 
3

 
2

 
134

 
(163
)
(2)
 
Balance, March 31, 2018
$
1,466

 
$
2,047

 
$
(2
)
 
$
(20,441
)
 
$
20,581

 
$
(3,900
)
 
$
350


(1) Accumulated other comprehensive income (loss) includes cumulative translation losses of $3,134 at March 31, 2019 ($2,832 at March 31, 2018) and $3,155 at December 31, 2018 ($2,927 at December 31, 2017), respectively, and unrecognized retirement plan and other retiree benefits costs of $1,026 at March 31, 2019 ($1,062 at March 31, 2018) and $1,038 at December 31, 2018 ($923 at December 31, 2017), respectively.

(2) As a result of the early adoption of ASU 2018-02, the Company reclassified the stranded tax effects in Accumulated other comprehensive income (loss) resulting from the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) to Retained earnings. See Note 2, Summary of Accounting Policies in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018 for additional information.

* Two dividends were declared in each of the first quarters of 2019 and 2018.

See Notes to Condensed Consolidated Financial Statements.

6


COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


1.
Basis of Presentation

The Condensed Consolidated Financial Statements reflect all normal recurring adjustments which, in management’s opinion, are necessary for a fair statement of the results for interim periods. Results of operations for interim periods may not be representative of results to be expected for a full year. Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) reclassifies certain prior year amounts, as applicable, to conform to the current year presentation.

For a complete set of financial statement notes, including the Company’s significant accounting policies, refer to the Company’s Annual Report on Form 10-K for the year ended December 31, 2018, filed with the Securities and Exchange Commission (the “SEC”).

2.
Use of Estimates

Provisions for certain expenses, including income taxes, advertising and consumer promotion, are based on full year assumptions and are included in the accompanying Condensed Consolidated Financial Statements in proportion with estimated annual tax rates, the passage of time or estimated annual sales, as applicable.

3.
Recent Accounting Pronouncements

In October 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2018-16, “Derivatives and Hedging (Topic 815): Inclusion of the Secured Overnight Financing Rate (“SOFR”) Overnight Index Swap (“OIS”) Rate as Benchmark Interest Rate for Hedge Accounting Purposes.” The new guidance permits the use of the OIS rate based on the SOFR as a U.S. benchmark interest rate for hedge accounting purposes under Topic 815. The new guidance was effective for the Company on a prospective basis beginning on January 1, 2019, concurrently with the adoption of ASU 2017-12 and did not have an impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-15, “Intangibles-Goodwill and Other-Internal-Use Software (Topic 350): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract.” This new guidance aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. This new guidance is effective for the Company on a prospective or retrospective basis beginning on January 1, 2020, with early adoption permitted. The Company elected to adopt this guidance early, beginning on January 1, 2019 on a prospective basis. The new guidance did not have a material impact on the Company’s Consolidated Financial Statements.

In August 2018, the FASB issued ASU No. 2018-14, “Compensation-Retirement Benefits-Defined Benefit Plans-General (Topic 715): Disclosure Framework-Changes to the Disclosure Requirements for Defined Benefit Plans.” This new guidance removes certain disclosures that are not considered cost beneficial, clarifies certain required disclosures and requires certain additional disclosures. This new guidance is effective for the Company on a retrospective basis beginning in the year ending December 31, 2020, with early adoption permitted. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.


7

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


In August 2018, the FASB issued ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” This new guidance removes certain disclosure requirements related to the fair value hierarchy, modifies existing disclosure requirements related to measurement uncertainty and adds new disclosure requirements. The new disclosure requirements include disclosing the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. This new guidance is effective for the Company beginning on January 1, 2020, with early adoption permitted. Certain disclosure requirements in the new guidance will need to be applied on a retrospective basis and others on a prospective basis. While the Company is currently assessing the impact of the new guidance, it is not expected to have a material impact on the Company’s Consolidated Financial Statements.

In August 2017, the FASB issued ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” amending the eligibility criteria for hedged items and transactions to expand an entity’s ability to hedge nonfinancial and financial risk components. The new guidance eliminates the requirement to separately measure and present hedge ineffectiveness and aligns the presentation of hedge gains and losses with the underlying hedge item. The new guidance also simplifies the hedge documentation and hedge effectiveness assessment requirements. The amended presentation and disclosure requirements must be adopted on a prospective basis, while any amendments to cash flow and net investment hedge relationships that exist on the date of adoption must be applied on a “modified retrospective” basis, meaning a cumulative effect adjustment to the opening balance of retained earnings as of the beginning of the year of adoption. The new guidance was effective for the Company on January 1, 2019 and did not have a material impact on the Company’s Consolidated Financial Statements.

In January 2017, the FASB issued ASU No. 2017-04, “Intangibles–Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment,” eliminating the requirement to calculate implied fair value, essentially eliminating step two from the goodwill impairment test. The new standard requires goodwill impairment to be based upon the results of step one of the impairment test, which is defined as the excess of the carrying value of a reporting unit over its fair value. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard is effective for the Company on a prospective basis beginning on January 1, 2020, with early adoption permitted. This new guidance is not expected to have an impact on the Company’s Consolidated Financial Statements.

In February 2016, the FASB issued its final standard on lease accounting, ASU No. 2016-02, “Leases (Topic 842),” which superseded Topic 840, “Leases,” which was further modified in ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” ASU No. 2018-11, “Leases (Topic 842) Targeted Improvements” and ASU No. 2019-01 “Leases (Topic 842) Codification Improvements” to clarify the implementation guidance. The new accounting standard was effective for the Company beginning on January 1, 2019 and required the recognition on the balance sheet of right-of-use assets and lease liabilities for all long-term leases, including operating leases, on the balance sheet. The Company elected the optional transition method and adopted the new guidance on January 1, 2019 on a modified retrospective basis with no restatement of prior period amounts. As allowed under the new accounting standard, the Company elected to apply practical expedients to carry forward the original lease determinations, lease classifications and accounting of initial direct costs for all asset classes at the time of adoption. The Company also elected not to separate lease components from non-lease components and to exclude short-term leases from its Consolidated Balance Sheet. The Company’s adoption of the new standard resulted in the recognition of right-of-use assets of $458 and liabilities of $574, with no material cumulative effect adjustment to equity as of the date of adoption. In connection with the adoption of this guidance, as required, the Company reclassified certain restructuring reserves incurred in connection with the Global Growth and Efficiency Program (see Note 4, Restructuring and Related Implementation Charges for additional information) and deferred rent liabilities as reductions to lease assets. Adoption of the new standard did not have a material impact on the Company’s Consolidated Statements of Income or Cash Flows. See Note 13, Leases for additional information.

8

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)



4.
Restructuring and Related Implementation Charges
 
In the fourth quarter of 2012, the Company commenced a restructuring program (the “Global Growth and Efficiency Program”). The program was expanded in 2014 and expanded and extended in each of 2015 and 2017. The program runs through December 31, 2019.

Initiatives under the Global Growth and Efficiency Program continue to fit within the program’s three focus areas of expanding commercial hubs, extending shared business services and streamlining global functions and optimizing the global supply chain and facilities.

Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax). The Company anticipates that pretax charges for 2019 will approximate $100 to $150 ($70 to $100 aftertax). It is expected that substantially all charges resulting from the Global Growth and Efficiency Program will be incurred by December 31, 2019.

The pretax charges resulting from the Global Growth and Efficiency Program are estimated to be comprised of the following categories: Employee-Related Costs, including severance, pension and other termination benefits (40%); asset-related costs, primarily Incremental Depreciation and Asset Impairments (10%); and Other charges, which include contract termination costs, consisting primarily of related implementation charges resulting directly from exit activities (30%) and the implementation of new strategies (20%). Over the course of the Global Growth and Efficiency Program, it is estimated that approximately 75% of the charges will result in cash expenditures.

The Company expects that the cumulative pretax charges, once all projects are approved and implemented, will relate to initiatives undertaken in North America (15%), Europe (20%), Latin America (5%), Asia Pacific (5%), Africa/Eurasia (5%), Hill’s Pet Nutrition (10%) and Corporate (40%), which includes substantially all of the costs related to the implementation of new strategies, noted above, on a global basis. The Company expects that, when it has been fully implemented, the Global Growth and Efficiency Program will have contributed a net reduction of approximately 4,000 to 4,400 positions from the Company’s global employee workforce.

For the three months ended March 31, 2019 and 2018, restructuring and related implementation charges are reflected in the Condensed Consolidated Statements of Income as follows:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Cost of sales
$
11

 
$
6

Selling, general and administrative expenses
4

 
5

Other (income) expense, net
13

 
13

Non-service related postretirement costs
1

 
4

Total Global Growth and Efficiency Program charges, pretax
$
29

 
$
28

 
 
 
 
Total Global Growth and Efficiency Program charges, aftertax
$
22

 
$
20


Restructuring and related implementation charges in the preceding table are recorded in the Corporate segment as these initiatives are predominantly centrally directed and controlled and are not included in internal measures of segment operating performance.

9

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Total charges incurred for the Global Growth and Efficiency Program relate to initiatives undertaken by the following reportable operating segments:

Three Months Ended

Program-to-date

March 31,

Accumulated Charges

2019

2018


North America
8
%

37
%

18
%
Latin America
40
%

12
%

5
%
Europe
8
%

2
%

19
%
Asia Pacific
6
%

18
%

4
%
Africa/Eurasia
%

2
%

6
%
Hills Pet Nutrition
12
%

19
%

8
%
Corporate
26
%

10
%

40
%
Total
100
%
 
100
%
 
100
%

Since the inception of the Global Growth and Efficiency Program in the fourth quarter of 2012, the Company has incurred cumulative pretax charges of $1,751 ($1,300 aftertax) in connection with the implementation of various projects as follows:
 
Cumulative Charges
 
as of March 31, 2019
Employee-Related Costs
$
691

Incremental Depreciation
97

Asset Impairments
58

Other
905

Total
$
1,751


The majority of costs incurred since inception relate to the following projects: the implementation of the Company’s overall hubbing strategy; the extension of shared business services and streamlining of global functions; the consolidation of facilities; the closing of the Morristown, New Jersey personal care facility; the simplification and streamlining of the Company’s research and development capabilities and oral care supply chain, both in Europe; redesigning the European commercial organization; restructuring how the Company will provide future retirement benefits to substantially all of the U.S.-based employees participating in the Company’s defined benefit retirement plan by shifting them to the Company’s defined contribution plan; and the implementation of a Corporate efficiencies program.

The following table summarizes the activity for the restructuring and related implementation charges discussed above and the related accruals:
 
 
Three Months Ended March 31, 2019
 
 
Employee-Related
Costs 
 
Incremental
Depreciation 
 
Asset
Impairments
 
Other
 
Total
Balance at December 31, 2018
 
$
60

 
$

 
$

 
$
142

 
$
202

Charges
 
10

 
5

 
6

 
8

 
29

Cash payments
 
(16
)
 

 

 
(8
)
 
(24
)
Charges against assets
 
(1
)
 
(5
)
 
(6
)
 

 
(12
)
Foreign exchange
 
(1
)
 

 

 

 
(1
)
Other
 

 

 

 
(48
)
 
(48
)
Balance at March 31, 2019
 
$
52

 
$

 
$

 
$
94

 
$
146



10

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Employee-Related Costs primarily include severance and other termination benefits and are calculated based on long-standing benefit practices, local statutory requirements and, in certain cases, voluntary termination arrangements. Employee-Related Costs also include pension and other retiree benefit enhancements amounting to $1 for the three months ended March 31, 2019, which are reflected as Charges against assets within Employee-Related Costs in the preceding table as the corresponding balance sheet amounts are reflected as a reduction of pension assets or an increase in pension and other retiree benefit liabilities. See Note 8, Retirement Plans and Other Retiree Benefits for additional information.

Incremental Depreciation is recorded to reflect changes in useful lives and estimated residual values for long-lived assets that will be taken out of service prior to the end of their normal service period. Asset Impairments are recorded to write down inventories and assets held for sale or disposal to their fair value based on amounts expected to be realized. Charges against assets within Asset Impairments are net of cash proceeds pertaining to the sale of certain assets.

Other charges consist primarily of charges resulting directly from exit activities and the implementation of new strategies as a result of the Global Growth and Efficiency Program. These charges for the three months ended March 31, 2019 include third-party incremental costs related to the development and implementation of new business and strategic initiatives of $5, and contract termination costs and charges resulting directly from exit activities of $3. These charges were expensed as incurred.

Other decreases to the restructuring accruals reflects the reclassification of restructuring accruals to lease assets as a result of the Company’s adoption of ASU No. 2018-10, “Codification Improvements to Topic 842, Leases,” on January 1, 2019. See Note 3, Recent Accounting Pronouncements and Note 13, Leases for additional information.

5.    Inventories

Inventories by major class are as follows:
 
March 31,
2019
 
December 31,
2018
Raw materials and supplies
$
242

 
$
253

Work-in-process
43

 
37

Finished goods
993

 
960

Total Inventories
$
1,278

 
$
1,250


6.    Earnings Per Share

For the three months ended March 31, 2019 and 2018, earnings per share were as follows:

 
Three Months Ended
 
March 31, 2019
 
March 31, 2018
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
 
Net income attributable to Colgate-Palmolive Company
 
Shares
(millions)
 
Per
Share
Basic EPS
$
560

 
862.0

 
$
0.65

 
$
634

 
875.4

 
$
0.72

Stock options and
restricted stock units
 
 
1.2

 
 

 
 

 
4.5

 
 

Diluted EPS
$
560

 
863.2

 
$
0.65

 
$
634

 
879.9

 
$
0.72


For the three months ended March 31, 2019 and 2018, the average number of stock options and restricted stock units that were anti-dilutive and not included in diluted earnings per share calculations were 21,980,033 and 16,287,263, respectively.



11

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


7.
Other Comprehensive Income (Loss)

Additions to and reclassifications out of Accumulated other comprehensive income (loss) attributable to the Company for the three months ended March 31, 2019 and 2018 were as follows:
 
 
2019
 
2018
 
 
Pretax
 
Net of Tax
 
Pretax
 
Net of Tax
 
 
 
 
 
 
 
 
 
Cumulative translation adjustments
 
$
27

 
$
21

 
$
96

 
$
105

Retirement plans and other retiree benefits:
 
 
 
 
 
 
 
 
Net actuarial gain (loss) and prior service costs arising during the period
 
(1
)
 
(1
)
 

 

Amortization of net actuarial loss, transition and prior service costs (1)
 
17

 
13

 
18

 
14

Retirement plans and other retiree benefits adjustments
 
16

 
12

 
18

 
14

Cash flow hedges:
 
 
 
 
 
 
 
 
Unrealized gains (losses) on cash flow hedges
 
(2
)
 
(2
)
 
(8
)
 
(6
)
Reclassification of (gains) losses into net earnings on cash flow hedges (2)
 
(4
)
 
(3
)
 
6

 
5

Gains (losses) on cash flow hedges
 
(6
)
 
(5
)
 
(2
)
 
(1
)
Total Other comprehensive income (loss)
 
$
37

 
$
28

 
$
112

 
$
118


(1) These components of Other comprehensive income (loss) are included in the computation of total pension cost. See Note 8, Retirement Plans and Other Retiree Benefits for additional details.
(2) These (gains) losses are reclassified into Cost of sales. See Note 12, Fair Value Measurements and Financial Instruments for additional details.

There were no tax impacts on Other comprehensive income (loss) attributable to Noncontrolling interests.

8.
Retirement Plans and Other Retiree Benefits

Components of Net periodic benefit cost for the three months ended March 31, 2019 and 2018 were as follows:

 
Pension Benefits
 
Other Retiree Benefits
 
United States
 
International
 
 
 
 
 
Three Months Ended March 31,
 
2019
 
2018
 
2019
 
2018
 
2019
 
2018
Service cost
$

 
$

 
$
4

 
$
4

 
$
4

 
$
4

Interest cost
23

 
21

 
5

 
6

 
11

 
10

Expected return on plan assets
(26
)
 
(29
)
 
(5
)
 
(6
)
 
(1
)
 

Amortization of actuarial loss (gain)
13

 
12

 
2

 
2

 
2

 
4

Net periodic benefit cost
$
10

 
$
4

 
$
6

 
$
6

 
$
16

 
$
18


For the three months ended March 31, 2019 and 2018, the Company made voluntary contributions to its U.S. postretirement plans of $102 and $0, respectively.


12

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


9.
Income Taxes

On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018.

The impact, if any, of further transitional tax guidance that may be issued by the U.S. Treasury would be reflected in the Company’s provision for income tax in the period such guidance is effective.

10.
Contingencies

As a global company serving consumers in more than 200 countries and territories, the Company is routinely subject to a wide variety of legal proceedings. These include disputes relating to intellectual property, contracts, product liability, marketing, advertising, foreign exchange controls, antitrust and trade regulation, as well as labor and employment, pension, data privacy and security, environmental and tax matters and consumer class actions. Management proactively reviews and monitors the Company’s exposure to, and the impact of, environmental matters. The Company is party to various environmental matters and, as such, may be responsible for all or a portion of the cleanup, restoration and post-closure monitoring of several sites.

The Company establishes accruals for loss contingencies when it has determined that a loss is probable and that the amount of loss, or range of loss, can be reasonably estimated. Any such accruals are adjusted thereafter as appropriate to reflect changes in circumstances.

The Company also determines estimates of reasonably possible losses or ranges of reasonably possible losses in excess of related accrued liabilities, if any, when it has determined that a loss is reasonably possible and it is able to determine such estimates. For those matters disclosed below for which the amount of any potential losses can be reasonably estimated, the Company currently estimates that the aggregate range of reasonably possible losses in excess of any accrued liabilities is $0 to approximately $225 (based on current exchange rates). The estimates included in this amount are based on the Company’s analysis of currently available information and, as new information is obtained, these estimates may change. Due to the inherent subjectivity of the assessments and the unpredictability of outcomes of legal proceedings, any amounts accrued or included in this aggregate amount may not represent the ultimate loss to the Company. Thus, the Company’s exposure and ultimate losses may be higher or lower, and possibly significantly so, than the amounts accrued or the range disclosed above.

Based on current knowledge, management does not believe that the ultimate resolution of loss contingencies arising from the matters discussed herein will have a material effect on the Company’s consolidated financial position or its ongoing results of operations or cash flows. However, in light of the inherent uncertainties noted above, an adverse outcome in one or more matters could be material to the Company’s results of operations or cash flows for any particular quarter or year.


13

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Brazilian Matters

There are certain tax and civil proceedings outstanding, as described below, related to the Companys 1995 acquisition of the Kolynos oral care business from Wyeth (the Seller).

The Brazilian internal revenue authority has disallowed interest deductions and foreign exchange losses taken by the Company’s Brazilian subsidiary for certain years in connection with the financing of the Kolynos acquisition. The tax assessments with interest, penalties and any court-mandated fees, at the current exchange rate, are approximately $151. This amount includes additional assessments received from the Brazilian internal revenue authority in April 2016 relating to net operating loss carryforwards used by the Company’s Brazilian subsidiary to offset taxable income that had also been deducted from the authority’s original assessments. The Company has been disputing the disallowances by appealing the assessments since October 2001. Appeals are currently pending at the administrative level. In the event the Company is ultimately unsuccessful in its administrative appeals, further appeals are available within the Brazilian federal courts.

In September 2015, the Company lost one of its appeals at the administrative level and filed a lawsuit in Brazilian federal court. In February 2017, the Company lost an additional administrative appeal and filed a lawsuit in Brazilian federal court. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the disallowances are without merit and that the Company should ultimately prevail. The Company is challenging these disallowances vigorously.
 
In July 2002, the Brazilian Federal Public Attorney filed a civil action against the federal government of Brazil, Laboratorios Wyeth-Whitehall Ltda. (the Brazilian subsidiary of the Seller) and the Company, as represented by its Brazilian subsidiary, in the 6th. Lower Federal Court in the City of São Paulo, seeking to annul an April 2000 decision by the Brazilian Board of Tax Appeals that found in favor of the Seller’s Brazilian subsidiary on the issue of whether it had incurred taxable capital gains as a result of the divestiture of Kolynos. The action seeks to make the Company’s Brazilian subsidiary jointly and severally liable for any tax due from the Seller’s Brazilian subsidiary. The case has been pending since 2002, and the Lower Federal Court has not issued a decision. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the Company should ultimately prevail in this action. The Company is challenging this action vigorously.

In December 2005, the Brazilian internal revenue authority issued to the Company’s Brazilian subsidiary a tax assessment with interest, penalties and any court-mandated fees of approximately $64, at the current exchange rate, based on a claim that certain purchases of U.S. Treasury bills by the subsidiary and their subsequent disposition during the period 2000 to 2001 were subject to a tax on foreign exchange transactions. The Company had been disputing the assessment within the internal revenue authority’s administrative appeals process. However, in November 2015, the Superior Chamber of Administrative Tax Appeals denied the Company’s final administrative appeal, and the Company has filed a lawsuit in the Brazilian federal court. In the event the Company is unsuccessful in this lawsuit, further appeals are available within the Brazilian federal courts. Although there can be no assurances, management believes, based on the opinion of its Brazilian legal counsel, that the tax assessment is without merit and that the Company should ultimately prevail. The Company is challenging this assessment vigorously.


14

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Competition Matters

Certain of the Company’s subsidiaries have historically been subject to investigations, and, in some cases, fines, by governmental authorities in a number of countries related to alleged competition law violations. Substantially all of these matters also involved other consumer goods companies and/or retail customers. The Company’s policy is to comply with antitrust and competition laws and, if a violation of any such laws is found, to take appropriate remedial action and to cooperate fully with any related governmental inquiry. The status of pending competition law matters as of March 31, 2019 is set forth below.

In December 2014, the French competition law authority found that 13 consumer goods companies, including the Company’s French subsidiary, exchanged competitively sensitive information related to the French home care and personal care sectors, for which the Company’s French subsidiary was fined $57. In addition, as a result of the Company’s acquisition of the Sanex personal care business in 2011 from Unilever N.V. and Unilever PLC (together with Unilever N.V., “Unilever,”), pursuant to a Business and Share Sale and Purchase Agreement (the “Sale and Purchase Agreement”), the French competition law authority found that the Company’s French subsidiary, along with Hillshire Brands Company (formerly Sara Lee Corporation (“Sara Lee”)), were jointly and severally liable for fines of $25 assessed against Sara Lee’s French subsidiary. The Company is indemnified for these fines by Unilever pursuant to the Sale and Purchase Agreement. The fines were confirmed by the Court of Appeal in October 2016. The Company appealed the decision of the Court of Appeal on behalf of the Company and Sara Lee in the French Supreme Court. In March 2019, the French Supreme Court denied the Company’s appeal.

In July 2014, the Greek competition law authority issued a statement of objections alleging a restriction of parallel imports into Greece. The Company responded to this statement of objections. In July 2017, the Company received the decision from the Greek competition law authority in which the Company was fined $11. The Company is appealing the decision to the Greek courts.

Talcum Powder Matters

The Company has been named as a defendant in civil actions alleging that certain talcum powder products that were sold prior to 1996 were contaminated with asbestos. Most of these actions involve a number of co-defendants from a variety of different industries, including suppliers of asbestos and manufacturers of products that, unlike the Company’s products, were designed to contain asbestos. As of March 31, 2019, there were 229 individual cases pending against the Company in state and federal courts throughout the United States, as compared to 239 cases as of December 31, 2018. During the three months ended March 31, 2019, 37 new cases were filed and 47 cases were resolved by voluntary dismissal or settlement. The value of settlements was not material, either individually or in the aggregate, to the Company’s results of operations for the quarter ended March 31, 2019.

The Company believes that a significant portion of its costs incurred in defending and resolving these claims will be covered by insurance policies issued by several primary, excess and umbrella insurance carriers, subject to deductibles, exclusions, retentions and policy limits.

While the Company and its legal counsel believe that these cases are without merit and intend to challenge them vigorously, there can be no assurances regarding the ultimate resolution of these matters. Since the amount of any potential losses from these cases currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to these cases.


15

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


ERISA Matter

In June 2016, a putative class action claiming that residual annuity payments made to certain participants in the Colgate-Palmolive Company Employees’ Retirement Income Plan (the “Plan”) did not comply with the Employee Retirement Income Security Act was filed against the Plan, the Company and certain individuals in the United States District Court for the Southern District of New York. This action has been certified as a class action. The relief sought includes recalculation of benefits, pre- and post-judgment interest and attorneys’ fees. The Company is contesting this action vigorously. Since the amount of any potential loss from this case currently cannot be reasonably estimated, the range of reasonably possible losses in excess of accrued liabilities disclosed above does not include any amount relating to the case.

11.
Segment Information

The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies to the Company’s Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2018. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Net sales by segment were as follows:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Net sales
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
853

 
$
827

Latin America
889

 
929

Europe
602

 
648

Asia Pacific
700

 
759

Africa/Eurasia
240

 
255

Total Oral, Personal and Home Care
3,284

 
3,418

Pet Nutrition
600

 
584

Total Net sales
$
3,884

 
$
4,002


Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe).

16

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The Company’s Net sales of Oral, Personal and Home Care and Pet Nutrition products accounted for the following percentages of the Company’s Net sales:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Net sales
 
 
 
Oral Care
48
%
 
49
%
Personal Care
19
%
 
19
%
Home Care
18
%
 
17
%
Pet Nutrition
15
%
 
15
%
Total Net sales
100
%
 
100
%

Operating profit by segment was as follows:
 
Three Months Ended
 
March 31,
 
2019
 
2018
Operating profit
 
 
 
Oral, Personal and Home Care
 
 
 
North America
$
249

 
$
257

Latin America
232

 
273

Europe
151

 
162

Asia Pacific
189

 
226

Africa/Eurasia
46

 
50

Total Oral, Personal and Home Care
867

 
968

Pet Nutrition
164

 
164

Corporate
(152
)
 
(149
)
Total Operating profit
$
879

 
$
983


For the three months ended March 31, 2019 and 2018, Corporate Operating profit (loss) included charges of $28 and $24, respectively, resulting from the Global Growth and Efficiency Program.

For further information regarding the Global Growth and Efficiency Program, refer to Note 4, Restructuring and Related Implementation Charges.


17

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


12.
Fair Value Measurements and Financial Instruments

The Company uses available market information and other valuation methodologies in assessing the fair value of financial instruments. Judgment is required in interpreting market data to develop the estimates of fair value and, accordingly, changes in assumptions or the estimation methodologies may affect the fair value estimates. The Company is exposed to the risk of credit loss in the event of nonperformance by counterparties to financial instrument contracts; however, nonperformance is considered unlikely and any nonperformance is unlikely to be material, as it is the Company’s policy to contract only with diverse, credit-worthy counterparties based upon both strong credit ratings and other credit considerations.

The Company is exposed to market risk from foreign currency exchange rates, interest rates and commodity price fluctuations. Volatility relating to these exposures is managed on a global basis by utilizing a number of techniques, including working capital management, sourcing strategies, selling price increases, selective borrowings in local currencies and entering into selective derivative instrument transactions, issued with standard features, in accordance with the Company’s treasury and risk management policies, which prohibit the use of derivatives for speculative purposes and leveraged derivatives for any purpose. It is the Company’s policy to enter into derivative instrument contracts with terms that match the underlying exposure being hedged.

The Company’s derivative instruments include interest rate swap contracts, foreign currency contracts and commodity contracts. The Company utilizes interest rate swap contracts to manage its targeted mix of fixed and floating rate debt, and these swaps are valued using observable benchmark rates (Level 2 valuation). The Company utilizes foreign currency contracts, including forward and swap contracts, option contracts, local currency deposits and local currency borrowings to hedge portions of its foreign currency purchases, assets and liabilities arising in the normal course of business and the net investment in certain foreign subsidiaries. These contracts are valued using observable market rates (Level 2 valuation). Commodity futures contracts are utilized to hedge the purchases of raw materials used in production. These contracts are measured using quoted commodity exchange prices (Level 1 valuation). The duration of foreign currency and commodity contracts generally does not exceed 12 months.

The company adopted ASU No. 2017-12, “Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities,” beginning on January 1, 2019. Refer to Note 3, Recent Accounting Pronouncements.

The following table summarizes the fair value of the Company’s derivative instruments and other financial instruments which are carried at fair value in the Company’s Consolidated Balance Sheets at March 31, 2019 and December 31, 2018:
 
Assets
 
Liabilities
 
 
Account
 
Fair Value
 
Account
 
Fair Value
Designated derivative instruments
 
 
3/31/19
 
12/31/18
 
 
 
3/31/19
 
12/31/18
Interest rate swap contracts
Other current assets
 
$

 
$

 
Other accruals
 
$

 
$
1

Interest rate swap contracts
Other assets
 

 

 
Other liabilities
 
4

 
8

Foreign currency contracts
Other current assets
 
14

 
20

 
Other accruals
 
13

 
8

Foreign currency contracts
Other assets
 

 

 
Other liabilities
 
15

 
21

Commodity contracts
Other current assets
 

 

 
Other accruals
 
1

 

Total designated
 
$
14

 
$
20

 
 
 
$
33

 
$
38

 
 
 
 
 
 
 
 
 
 
 
 
Other financial instruments
 
 
 

 
 

 
 
 
 

 
 

Marketable securities
Other current assets
 
$
37

 
$
10

 
 
 
 

 
 

Total other financial instruments
 
 
$
37

 
$
10

 
 
 
 

 
 


18

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The carrying amount of cash, cash equivalents, accounts receivable and short-term debt approximated fair value as of March 31, 2019 and December 31, 2018. The estimated fair value of the Company’s long-term debt, including the current portion, as of March 31, 2019 and December 31, 2018, was $6,783 and $6,434, respectively, and the related carrying value was $6,656 and $6,354, respectively. The estimated fair value of long-term debt was derived principally from quoted prices on the Company’s outstanding fixed-term notes (Level 2 valuation).

The following amounts were recorded on the Condensed Consolidated Balance Sheet related to cumulative basis adjustment for fair value hedges as of:
 
March 31, 2019
 
December 31, 2018
Long-term debt:
 
 
 
Carrying amount of hedged item
$
394

 
$
888

Cumulative hedging adjustment included in the carrying amount
4

 
10


The following table presents the notional values as of:
 
March 31, 2019
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
708

 
$

 
$
400

 
$

 
$
1,108

Cash Flow Hedges
791

 

 

 
12

 
803

Net Investment Hedges
490

 
2,212

 

 

 
2,702


 
December 31, 2018
 
Foreign
Currency
Contracts
 
Foreign Currency Debt
 
Interest Rate Swaps
 
Commodity Contracts
 
 
Total
Fair Value Hedges
$
327

 
$

 
$
900

 
$

 
$
1,227

Cash Flow Hedges
782

 

 

 
14

 
796

Net Investment Hedges
482

 
1,396

 

 

 
1,878



19

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


The following table presents the location and amount of gains (losses) recognized on the Company’s Condensed Consolidated Statements of Income:
 
Three Months Ended
March 31,
 
2019
 
2018
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
 
Cost of sales
 
Selling, general and administrative expenses
 
Interest (income) expense, net
Gain (loss) on hedges recognized in income:
 
 
 
 
 
 
 
 
 
 
 
Interest rate swaps designated as fair value hedges:
 
 
 
 
 
 
 
 
 
 
 
Derivative instrument
$

 
$

 
$
(3
)
 
$

 
$

 
$
(10
)
Hedged items

 

 
3

 

 

 
10

Foreign currency contracts designated as fair value hedges:
 
 
 
 
 
 

 

 

Derivative instrument

 
(1
)
 

 

 
(13
)
 

Hedged items

 
1

 

 

 
13

 

Foreign currency contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
3

 

 

 
(6
)
 

 

Commodity contracts designated as cash flow hedges:
 
 
 
 
 
 

 

 

Amount reclassified from OCI
1

 

 

 

 

 

Total gain (loss) on hedges recognized in income
$
4

 
$

 
$

 
$
(6
)
 
$

 
$


The following table presents the location and amount of unrealized gains (losses) included in Other Comprehensive Income (OCI):
 
Three Months Ended
March 31,
2019
 
2018
Foreign currency contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
$
(3
)
 
$
(8
)
Commodity contracts designated as cash flow hedges:
 
 
 
Gain (loss) recognized in OCI
1

 

Foreign currency contracts designated as net investment hedges:
 
 
 
Gain (loss) on instruments
6

 
(18
)
Gain (loss) on hedged items
(6
)
 
18

Foreign currency debt designated as net investment hedges:
 
 
 
Gain (loss) on instruments
29

 
(19
)
Gain (loss) on hedged items
(29
)
 
19

Total unrealized gain (loss) on hedges recognized in other comprehensive income (OCI)
$
(2
)
 
$
(8
)




20

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


13. Leases

The Company adopted ASU No. 2016-02 “Leases (Topic 842)” on January 1, 2019, resulting in the recognition of right-of-use assets of $458 and liabilities of $574. The Company enters into leases for land, office space, warehouses and equipment. A number of the leases include one or more options to renew the lease terms, purchase the leased property or terminate the lease. The exercise of these options is at the Company’s discretion and is therefore recognized on the balance sheet when it is reasonably certain the Company will exercise such options.

Substantially all of the Company’s leases are considered operating leases. Finance leases were not material as of March 31, 2019 or for the three months ended March 31, 2019.

As of March 31, 2019, the Companys right-of use assets and liabilities for operating leases were as follows:
Other assets
$
422

 
 
Other accruals
$
161

Other liabilities
369

Total operating lease liabilities
$
530


Lease commitments under noncancellable operating leases were as follows:
Years Ending December 31,
As of
March 31, 2019
 
As of
December 31, 2018
2019
$
137

*
$
193

2020
154

 
165

2021
119

 
123

2022
97

 
102

2023
45

 
51

Thereafter
21

 
32

Total lease commitments
$
573

 
$
666

Less: Interest
(43
)
 
 
Present value of lease liabilities
$
530

 
 
* As of March 31, 2019, $137 represents the lease commitments for the nine-months remaining until December 31, 2019.

The components of the Company’s operating lease cost for the three months ended March 31, 2019 were as follows:
Operating lease cost
$
45

Short-term lease cost
2

Variable lease cost
10

Sublease income

Total lease cost
$
57


Short-term lease cost represents the Company’s cost with respect to leases with a duration of 12 months or less and are not reflected on the Company’s Consolidated Balance Sheets. Variable lease costs are comprised of costs such as the Company’s proportionate share of actual costs for utilities, common area maintenance, property taxes and insurance that are not included in the lease liability and are recognized in the period in which they are incurred.


21

COLGATE-PALMOLIVE COMPANY
 Notes to Condensed Consolidated Financial Statements (continued)
(Dollars in Millions Except Share and Per Share Amounts)
(Unaudited)


Supplemental cash flow information related to operating leases for the three months ended March 31, 2019 was as follows:
Payments against amounts included in the measurement of lease liabilities: $57
Lease assets obtained in exchange for lease liabilities: $22

The weighted-average remaining lease term for operating leases was 4 years. The weighted-average discount rate for operating leases was 4.0%.

There were no material operating leases that the Company had entered into and that were yet to commence as of March 31, 2019.


22

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Executive Overview

Colgate-Palmolive Company (together with its subsidiaries, the “Company” or “Colgate”) seeks to deliver strong, consistent business results and superior shareholder returns by providing consumers globally with products that make their lives healthier and more enjoyable.

To this end, the Company is tightly focused on two product segments: Oral, Personal and Home Care; and Pet Nutrition. Within these segments, the Company follows a closely defined business strategy to grow our key product categories and increase our overall market share. Within the categories in which the Company competes, the Company prioritizes its efforts based on their capacity to maximize the use of the organization’s core competencies and strong global equities and to deliver sustainable long-term growth.

Operationally, the Company is organized along geographic lines with management teams having responsibility for the business and financial results in each region. The Company competes in more than 200 countries and territories worldwide with established businesses in all regions contributing to the Company’s sales and profitability. Approximately 70% of the Company’s Net sales are generated from markets outside the U.S., with approximately 50% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). This geographic diversity and balance help to reduce the Company’s exposure to business and other risks in any one country or part of the world.

The Oral, Personal and Home Care product segment is managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia, all of which sell to a variety of traditional and eCommerce retailers, wholesalers and distributors. The Company, through Hill’s Pet Nutrition, also competes on a worldwide basis in the pet nutrition market, selling its products principally through authorized pet supply retailers, veterinarians and eCommerce retailers.

On an ongoing basis, management focuses on a variety of key indicators to monitor business health and performance. These indicators include market share, net sales (including volume, pricing and foreign exchange components), organic sales growth (net sales growth excluding, as applicable, the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, and gross profit margin, operating profit, net income and earnings per share, in each case, on a GAAP and non-GAAP basis, as well as measures used to optimize the management of working capital, capital expenditures, cash flow and return on capital. The monitoring of these indicators and the Company’s Code of Conduct and corporate governance practices help to maintain business health and strong internal controls. For additional information regarding non-GAAP financial measures, see “Non-GAAP Financial Measures” below.

To achieve its business and financial objectives, the Company focuses the organization on initiatives to drive and fund growth. The Company seeks to capture significant opportunities for growth by identifying and meeting consumer needs within its core categories, through its focus on innovation and the deployment of valuable consumer and shopper insights in the development of successful new products. To enhance these efforts, the Company has developed key initiatives to build strong relationships with consumers, dental, veterinary and skin care professionals and traditional and eCommerce retailers. In addition, the Company has enhanced its digital marketing capabilities and intends to broaden its eCommerce offerings, including direct-to-consumer and subscription services. Growth opportunities are greater in those areas of the world in which economic development and rising consumer incomes expand the size and number of markets for the Company’s products.
The investments needed to support growth are developed through continuous, Company-wide initiatives to lower costs and increase effective asset utilization. Through these initiatives, which are referred to as the Company’s funding-the-growth initiatives, the Company seeks to become even more effective and efficient throughout its businesses. These initiatives are designed to reduce costs associated with direct materials, indirect expenses, distribution and logistics, and advertising and promotional materials, among other things, and encompass a wide range of projects, examples of which include raw material substitution, reduction of packaging materials, consolidating suppliers to leverage volumes and increasing manufacturing efficiency through SKU reductions and formulation simplification. The Company also continues to prioritize its investments toward its higher margin businesses, specifically Oral Care, Personal Care and Pet Nutrition.


23

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Significant Items Impacting Comparability
On December 22, 2017, the Tax Cuts and Jobs Act (the “TCJA” or “U.S. tax reform”) was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain future earnings generated by foreign subsidiaries while providing for future tax-free repatriation of such earnings through a 100% dividends-received deduction.
During 2018, the Company finalized its assessment of the impact of the TCJA and recognized tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018. Any further guidance issued after December 31, 2018 may have an impact to the Company’s Provision for income tax in the period such guidance is effective. Refer to “Results of Operations-Income Taxes” below for additional details.
The Company’s restructuring program known as the “Global Growth and Efficiency Program,” runs through December 31, 2019. The program’s initiatives are expected to help the Company ensure sustained solid worldwide growth in unit volume, organic sales, operating profit and earnings per share and to enhance its global leadership positions in its core businesses. Implementation of the Global Growth and Efficiency Program remains on track and is in its final year.
The initiatives under the Global Growth and Efficiency Program are focused on the following areas:
Expanding Commercial Hubs
Extending Shared Business Services and Streamlining Global Functions
Optimizing Global Supply Chain and Facilities

Savings, substantially all of which are expected to increase future cash flows, are projected to be in the range of $590 to $635 pretax ($550 to $575 aftertax) annually, once all projects are approved and implemented. Cumulative pretax charges resulting from the Global Growth and Efficiency Program, once all phases are approved and implemented, are estimated to be in the range of $1,820 to $1,870 ($1,350 to $1,380 aftertax).

In the three months ended March 31, 2019 and 2018, the Company incurred aftertax costs of $22 and $20, respectively, resulting from the Global Growth and Efficiency Program.

For more information regarding the Global Growth and Efficiency Program, see “Restructuring and Related Implementation Charges” below and Note 4, Restructuring and Related Implementation Charges to the Condensed Consolidated Financial Statements.


24

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Outlook

Looking forward, the Company expects global macroeconomic and market conditions to remain challenging. While the Company has recently seen improvement in category growth rates, the Company expects category growth rates to remain below historical levels. While the global marketplace in which the Company operates has always been highly competitive, the Company continues to experience heightened competitive activity in certain markets from strong local competitors and from other large multinational companies, some of which have greater resources than the Company does. Such activities have included more aggressive product claims and marketing challenges, as well as increased promotional spending and geographic expansion. The Company has also been negatively affected by changes in the policies or practices of its retail trade customers in key markets, such as inventory de-stocking, limitations on access to shelf space or delisting of the Company’s products. In addition, the retail landscape in many of the Company’s markets continues to be impacted by the rapid growth of eCommerce retailers, changing consumer preferences (as consumers increasingly shop online) and the emergence of alternative retail channels, such as subscription services and direct-to-consumer businesses. This rapid growth in eCommerce and emergence of alternative retail channels may create pricing pressures and/or adversely affect the Company’s relationships with its key retailers. In addition, given that approximately 70% of the Company’s Net sales originate in markets outside the U.S., the Company has experienced and may continue to experience volatile foreign currency fluctuations and high raw and packaging material costs. While the Company has taken, and will continue to take, measures to mitigate the effect of these conditions, should they persist, they could adversely affect the Company’s future results.

In summary, the Company believes it is well prepared to meet the challenges ahead due to its strong financial condition, experience operating in challenging environments and continued focus on the Company’s key priorities: growing sales through engaging with consumers, developing world-class innovation and working with retail partners; driving efficiency on every line of the income statement to increase margins; generating strong cash flow performance and utilizing that cash effectively to enhance total shareholder return; and leading to win by staying true to the Company’s culture and focusing on its stakeholders. The Company’s commitment to these priorities, together with the strength of the Company’s global brands, its broad international presence in both developed and emerging markets and cost-saving initiatives, such as the Company’s funding-the-growth initiatives and the Global Growth and Efficiency Program, should position the Company well to increase shareholder value over the long term.




25

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Results of Operations

Three Months

Worldwide Net sales were $3,884 in the first quarter of 2019, down 3.0% from the first quarter of 2018, as volume growth of 1.0% and net selling price increases of 2.0% were more than offset by negative foreign exchange of 6.0%. Organic sales (Net sales excluding the impact of foreign exchange, acquisitions and divestments), a non-GAAP financial measure, increased 3.0% in the first quarter of 2019. A reconciliation of net sales growth to organic sales growth is provided under “Non-GAAP Financial Measures” below.

Net sales in the Oral, Personal and Home Care product segment were $3,284 in the first quarter of 2019, down 4.0% from the first quarter of 2018, as volume growth of 1.0% and net selling price increases of 1.5% were more than offset by negative foreign exchange of 6.5%. Organic sales in the Oral, Personal and Home Care product segment increased 2.5% in the first quarter of 2019.

The Company’s share of the global toothpaste market was 41.7% on a year-to-date basis, down 1.0 share point from the year ago period, and its share of the global manual toothbrush market was 31.6% on a year-to-date basis, down 1.1 share points from the year ago period. Year-to-date market shares in toothpaste were up in Africa/Eurasia and down in North America, Latin America, Europe and Asia Pacific versus the comparable 2018 period. In the manual toothbrush category, year-to-date market shares were down in North America, Latin America, Europe, Asia Pacific and Africa/Eurasia versus the comparable 2018 period. For additional information regarding market shares, see “Market Share Information” below.

Net sales in the Hill’s Pet Nutrition segment were $600 in the first quarter of 2019, up 3.0% from the first quarter of 2018, as volume growth of 2.0% and net selling price increases of 4.0% were partially offset by negative foreign exchange of 3.0%. Organic sales in the Hill’s Pet Nutrition segment increased 6.0% in the first quarter of 2019.

Gross Profit/Margin

Worldwide Gross profit decreased to $2,287 in the first quarter of 2019 from $2,408 in the first quarter of 2018. Gross profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Gross profit decreased to $2,298 in the first quarter of 2019 from $2,414 in the first quarter of 2018. This decrease in Gross profit reflects a decrease of $72 resulting from lower Net sales and a decrease of $44 resulting from lower Gross profit margin.

Worldwide Gross profit margin decreased to 58.9% in the first quarter of 2019 from 60.2% in the first quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Gross profit margin decreased by 110 basis points (bps) to 59.2% in the first quarter of 2019 from 60.3% in the first quarter of 2018. This decrease in Gross profit margin was due to higher raw and packaging material costs (320 bps), which included foreign exchange transaction costs, partially offset by cost savings from the Company’s funding-the-growth initiatives (150 bps) and higher pricing (70 bps).
 
 
Three Months Ended March 31,
 
 
2019
 
2018
Gross profit, GAAP
 
$
2,287

 
$
2,408

Global Growth and Efficiency Program
 
11

 
6

Gross profit, non-GAAP
 
$
2,298

 
$
2,414


 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
Basis Point Change
Gross profit margin, GAAP
 
58.9
%
 
60.2
%
 
(130
)
Global Growth and Efficiency Program
 
0.3

 
0.1

 
 
Gross profit margin, non-GAAP
 
59.2
%
 
60.3
%
 
(110
)

26

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Selling, General and Administrative Expenses

Selling, general and administrative expenses decreased 2% to $1,365 in the first quarter of 2019 from $1,392 in the first quarter of 2018. Selling, general and administrative expenses in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Selling, general and administrative expenses decreased to $1,361 in the first quarter of 2019 from $1,387 in the first quarter of 2018, reflecting lower overhead expenses of $39, partially offset by increased advertising investment of $13.
 
Selling, general and administrative expenses as a percentage of Net sales increased to 35.1% in the first quarter of 2019 from 34.8% in the first quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Selling, general and administrative expenses as a percentage of Net sales increased by 30 bps to 35.0% in the first quarter of 2019 as compared to 34.7% in the first quarter of 2018. This increase was due to increased advertising investment (60 bps), partially offset by lower overhead expenses (30 bps), both as a percentage of Net sales. In the first quarter of 2019, advertising investment increased as a percentage of Net sales to 11.0% from 10.4% in the first quarter of 2018 or 3% in absolute terms to $429, as compared with $416 in the first quarter of 2018.

 
 
Three Months Ended March 31,
 
 
2019
 
2018
Selling, general and administrative expenses, GAAP
 
$
1,365

 
$
1,392

Global Growth and Efficiency Program
 
(4
)
 
(5
)
Selling, general and administrative expenses, non-GAAP
 
$
1,361

 
$
1,387


 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
Basis Point Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP
 
35.1
 %
 
34.8
 %
 
30
Global Growth and Efficiency Program
 
(0.1
)
 
(0.1
)
 
 
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP
 
35.0
 %
 
34.7
 %
 
30



27

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Operating Profit

Operating profit decreased 11% to $879 in the first quarter of 2019 from $983 in the first quarter of 2018. Operating profit in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Operating profit decreased 10% to $907 in the first quarter of 2019 from $1,007 in the first quarter of 2018, as a decrease in Gross profit was partially offset by a decrease in Selling, general and administrative expenses.

Operating profit margin was 22.6% in the first quarter of 2019, a decrease of 200 bps compared to 24.6% in the first quarter of 2018. Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Operating profit margin was 23.4% in the first quarter of 2019, a decrease of 180 bps compared to 25.2% in the first quarter of 2018. This decrease in Operating profit margin was primarily due to a decrease in Gross profit (110 bps) and an increase in Selling, general and administrative expenses (30 bps), both as a percentage of Net sales.

 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
% Change
Operating profit, GAAP
 
$
879

 
$
983

 
(11
)%
Global Growth and Efficiency Program
 
28

 
24

 
 
Operating profit, non-GAAP
 
$
907

 
$
1,007

 
(10
)%

 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
Basis Point Change
Operating profit margin, GAAP
 
22.6
%
 
24.6
%
 
(200
)
Global Growth and Efficiency Program
 
0.8

 
0.6

 
 
Operating profit margin, non-GAAP
 
23.4
%
 
25.2
%
 
(180
)

Non-Service Related Postretirement Costs

Non-service related postretirement costs were $25 in the first quarter of 2019, as compared to $24 in the first quarter of 2018. Non-service related postretirement costs in both periods included charges resulting from the Global Growth and Efficiency Program. Excluding these charges in both periods, Non-service related postretirement costs were $24 in the first quarter of 2019, as compared to $20 in the first quarter of 2018.

 
 
Three Months Ended March 31,
 
 
2019
 
2018
Non-service related postretirement costs, GAAP
 
$
25

 
$
24

Global Growth and Efficiency Program
 
(1
)
 
(4
)
Non-service related postretirement costs, non-GAAP
 
$
24

 
$
20


Interest (Income) Expense, Net

Interest (income) expense, net was $40 in the first quarter of 2019 as compared to $35 in the first quarter of 2018, primarily due to higher average interest rates on debt.


28

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Income Taxes

The effective income tax rate was 26.3% for the first quarter of 2019 as compared to 26.6% for the first quarter of 2018. As reflected in the table below, the non-GAAP effective income tax rate was 26.2% for the first quarter of 2019, as compared to 26.7% in the comparable period of 2018.

The quarterly provision for income taxes is determined based on the Companys estimated full year effective income tax rate adjusted by the amount of tax attributable to infrequent or unusual items that are separately recognized on a discrete basis in the income tax provision in the quarter in which they occur. The Companys current estimate of its full year effective income tax rate before discrete period items is 26.1%, compared to 27.3% in the first quarter of 2018.
 
 
Three Months Ended March 31,
 
 
2019
 
2018
 
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Effective Income Tax Rate(2)
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Effective Income Tax Rate(2)
As Reported GAAP
 
$
814

 
$
214

 
26.3
 %
 
$
924

 
$
246

 
26.6
%
Global Growth and Efficiency Program
 
29

 
7

 
(0.1
)
 
28

 
8

 
0.1

Non-GAAP
 
$
843

 
$
221

 
26.2
 %
 
$
952

 
$
254

 
26.7
%
(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.
 
On December 22, 2017, the TCJA was enacted, which, among other things, lowered the U.S. corporate income tax rate to 21% from 35% and established a modified territorial system requiring a mandatory deemed repatriation tax on undistributed earnings of foreign subsidiaries. Beginning in 2018, the TCJA also requires a minimum tax on certain earnings generated by foreign subsidiaries while providing for tax-free repatriation of such earnings through a 100% dividends-received deduction. The Company’s effective income tax rate in 2017 included a provisional charge of $275, recorded in the fourth quarter of 2017, based on its initial analysis of the TCJA. During 2018, the Company finalized its assessment of the impact of the TCJA and recognized an additional tax expense of $80 reflecting the impact of transition tax guidance issued by the U.S. Treasury and the update of certain estimates and calculations based on information available through the end of 2018.

The impact, if any, of further transitional tax guidance that may be issued by the U.S. Treasury would be reflected in the Company’s provision for income tax in the period such guidance is effective.


29

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Net Income Attributable to Colgate-Palmolive Company and Earnings Per Share

Net income attributable to Colgate-Palmolive Company for the first quarter of 2019 decreased to $560 from $634 in the first quarter of 2018, and Earnings per common share on a diluted basis decreased to $0.65 per share in the first quarter of 2019 from $0.72 in the first quarter of 2018. Net income attributable to Colgate-Palmolive Company in both periods included charges resulting from the Global Growth and Efficiency Program.

Excluding charges resulting from the Global Growth and Efficiency Program in both periods, Net income attributable to Colgate-Palmolive Company in the first quarter of 2019 decreased 11% to $582 from $654 in the first quarter of 2018, and Earnings per common share on a diluted basis decreased 9% to $0.67 in the first quarter of 2019 from $0.74 in the first quarter of 2018.
 
Three Months Ended March 31, 2019
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Net Income Including Noncontrolling Interests
 
Net Income Attributable To Colgate-Palmolive Company
 
Diluted Earnings Per Share(2)
As Reported GAAP
$
814

 
$
214

 
$
600

 
$
560

 
$
0.65

Global Growth and Efficiency Program
29

 
7

 
22

 
22

 
0.02

Non-GAAP
$
843

 
$
221

 
$
622

 
$
582

 
$
0.67


 
Three Months Ended March 31, 2018
 
Income Before Income Taxes
 
Provision For Income Taxes(1)
 
Net Income Including Noncontrolling Interests
 
Net Income Attributable To Colgate-Palmolive Company
 
Diluted Earnings Per Share(2)
As Reported GAAP
$
924

 
$
246

 
$
678

 
$
634

 
$
0.72

Global Growth and Efficiency Program
28

 
8

 
20

 
20

 
0.02

Non-GAAP
$
952

 
$
254

 
$
698

 
$
654

 
$
0.74

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.
(2) The impact of non-GAAP adjustments on diluted earnings per share may not necessarily equal the difference between “GAAP” and “non-GAAP” as a result of rounding.

30

COLGATE-PALMOLIVE COMPANY
Managements Discussion and Analysis of Financial
Condition and Results of Operations
(Dollars in Millions Except Per Share Amounts)


Net Sales and Operating Profit by Segment

Oral, Personal and Home Care

North America
 
Three Months Ended March 31,
 
2019
 
2018